ReNeuron Group Plc Stock price London S.E.
Equities
Biotechnology & Medical Research
Sales 2022 | 403K 509K | Sales 2023 | 530K 670K | Capitalization | 5.17M 6.54M |
---|---|---|---|---|---|
Net income 2022 | -9M -11.37M | Net income 2023 | -5M -6.32M | EV / Sales 2022 | 8.48 x |
Net cash position 2022 | 13.99M 17.67M | Net cash position 2023 | 6.73M 8.51M | EV / Sales 2023 | -2.94 x |
P/E ratio 2022 |
-1.79
x | P/E ratio 2023 |
-0.96
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 79.3% |
Latest transcript on ReNeuron Group Plc
Managers | Title | Age | Since |
---|---|---|---|
John Hawkins
DFI | Director of Finance/CFO | 58 | 14-09-30 |
Suzanne Hancock
COO | Chief Operating Officer | - | 16-12-31 |
Chief Tech/Sci/R&D Officer | - | 22-03-02 |
Members of the board | Title | Age | Since |
---|---|---|---|
Martin Walton
BRD | Director/Board Member | 61 | 22-03-21 |
Iain Ross
CHM | Chairman | 71 | 21-06-30 |
Director/Board Member | 61 | 21-07-13 |
1st Jan change | Capi. | |
---|---|---|
+7.63% | 45.97B | |
+53.58% | 43.93B | |
+9.80% | 42.34B | |
-8.59% | 28.27B | |
+15.79% | 27.18B | |
-19.35% | 19.44B | |
+13.68% | 13.83B | |
+31.83% | 12.4B | |
+10.73% | 11.45B |